pcnindiaglobal
September 24, 2026October 12, 2026
CDSCO, Compliance Guides, Import Compliance, Medical Devices

CDSCO Licence for Dengue & Malaria Rapid Test Kits in India: Class C IVD Registration and Process

Dengue and malaria rapid test kits detect vector-borne infections that are seasonal and widespread across India, and a wrong result delays urgent treatment. Because they detect infectious agents, CDSCO regulates these rapid kits as Class C in-vitro diagnostics (IVDs), with validated performance-evaluation evidence behind the licence. This guide covers the full CDSCO registration pathway for dengue and malaria test kits under the Medical Devices Rules, 2017 — classification, licence route, the performance evidence, the documents, the fees and the timeline.

Is a CDSCO Licence Mandatory for Dengue & Malaria Test Kits?

Yes. Dengue and malaria test kits are notified in-vitro diagnostics and cannot be manufactured, imported or sold in India without a CDSCO licence. Because detecting an infectious agent is Class C, a domestic manufacturer applies to the Central Licensing Authority in Form MD-7 for a Form MD-9 licence, and an importer applies in Form MD-14 for a Form MD-15 import licence. Kit performance is validated at a designated evaluation laboratory (e.g. ICMR/NIMR-linked) before grant.

Risk Classification of Dengue & Malaria Test Kits

Every medical device in India is placed in one of four risk classes (A, B, C, D) under the First Schedule of the Medical Devices Rules, 2017. The class fixes the authority, the form, the fee, the audit route and the timeline.

Dengue & Malaria Test Kits are classified as Class C (moderate-to-high risk). An IVD that detects an infectious agent (dengue virus or malaria parasite), where an incorrect result carries a significant risk to the patient, is classified at Class C under the IVD classification rules. Where a device could fall in two classes the higher class applies, and an accessory is classified in its own right; always confirm against the current CDSCO classification list.

Which CDSCO Licence You Need for Dengue & Malaria Test Kits

To manufacture dengue & malaria test kits in India (Class C) — apply in Form MD-7 to the Central Licensing Authority (CDSCO headquarters); the licence is granted in Form MD-9. A CDSCO joint audit team inspects the manufacturing site before the licence is granted — site inspection is mandatory for Class C and D.
To import dengue & malaria test kits (any class) — the overseas manufacturer appoints an Indian Authorised Agent who files Form MD-14 with the Central Licensing Authority; the import licence is granted in Form MD-15.
Test licence — for a small quantity imported or made for testing, evaluation, demonstration or clinical investigation: Form MD-12 application, Form MD-13 licence.
Loan licence — using another licensee’s approved premises: Form MD-4 (Class A/B) or Form MD-8 (Class C/D) for a licence in Form MD-6 or MD-10.

Applicable Standards for Dengue & Malaria Test Kits

Dengue and malaria kits are evaluated principally on performance evidence, supported by IVD quality and labelling standards:

Performance Evaluation Report (PER) — clinical sensitivity and specificity against reference methods, at a designated evaluation laboratory.
National programme validation (e.g. ICMR/NIMR panels) where applicable for dengue and malaria assays.
ISO 13485 — quality management system for the IVD manufacturer.
ISO 23640 — stability evaluation of the IVD reagents.
ISO 14971 — risk management, including false-negative consequences.
ISO 18113 — IVD labelling and information supplied by the manufacturer.

Documents Required for Dengue & Malaria Test Kits CDSCO Licensing

Whether you file for a manufacturing or an import licence, CDSCO expects the same core technical dossier built around the device:

Covering letter and application form — Form MD-3 / MD-7 (manufacture) or Form MD-14 (import) on the CDSCO Medical Device Online portal, stating every device, variant and site.
Device Master File (DMF) — device description and intended use, materials, design and manufacturing information, ISO 14971 risk file, verification/validation data, sterilisation validation where applicable, shelf-life/stability data and the Essential Principles checklist.
Plant Master File (PMF) — site layout, equipment, utilities/HVAC, organisation chart with competent technical staff and the QMS procedures governing production.
ISO 13485 QMS certificate — current, with a scope covering the device.
Essential Principles of Safety and Performance — a completed checklist mapping the device against each applicable principle with the standard/evidence relied on.
Risk management file (ISO 14971) — hazards, risk controls and residual-risk justification.
Test / performance reports — against the applicable BIS/IS or ISO/IEC standards from an accredited laboratory.
Labels, IFU and packaging — meeting the labelling requirements of the Medical Devices Rules (manufacturer, licence number, sterile status, single-use symbols).
Undertaking and declaration of conformity to the Essential Principles and applicable standards.
Government fee receipt — paid online through the CDSCO portal.

Device-specific documents on top of the core set for dengue & malaria test kits:

Performance Evaluation Report from a designated laboratory — sensitivity/specificity for each analyte (dengue NS1/IgM/IgG; malaria Pf/Pv).
Analytical evidence — limit of detection, cross-reactivity (e.g. other flaviviruses) and interference.
Stability (ISO 23640) data — kit shelf-life and transport stability under Indian conditions.
Panel results against characterised positive/negative specimens.
Lot-to-lot consistency data.
Country-of-origin approval / Free Sale Certificate for imports.

For an import licence (Form MD-14) there are three further essentials:

Free Sale Certificate (FSC) — from the National Regulatory Authority of the country of origin, legalised (apostille/embassy attestation).
Country-of-origin regulatory approval — US FDA 510(k)/PMA, EU CE certificate or equivalent.
Power of Attorney and Authorised Agent licence — notarised, legalised PoA to the Indian Authorised Agent, plus the agent’s valid wholesale/manufacturing licence.

QMS & Essential Principles — What CDSCO Checks

Essential Principles of Safety and Performance (Fifth Schedule) — the device must be safe and perform as intended, with risks reduced as far as possible; shown through recognised standards and the risk-management file.
Quality Management System (ISO 13485) — design controls, supplier control, process validation, traceability, complaint handling and CAPA, evidenced at audit.
Risk management (ISO 14971) — a living file with residual risks justified and communicated in the IFU.
Clinical evidence — proportionate to the class: clinical evaluation for lower-risk devices and clinical investigation data for many Class C/D and novel devices.

Label & IFU Requirements Specific to Dengue & Malaria Test Kits

IVD labelling (ISO 18113) is checked for analyte, lot and expiry information:

Product name, IVD symbol, the analytes (dengue NS1/IgM/IgG; malaria Pf/Pv) and specimen type.
Manufacturer name and address, and the CDSCO licence number.
Lot/batch number, date of manufacture and expiry date.
Storage conditions and the reading time-window.
Result interpretation and confirmatory-testing guidance in the IFU.

Analyte Scope and the Designated-Lab Validation

Dengue and malaria kits come in several analyte configurations — dengue NS1 antigen, IgM/IgG antibodies, and combo cards; malaria Pf/Pv (and pan-species) — and each analyte claimed must be evidenced. Common to all is validation at a designated evaluation laboratory (often linked to ICMR/NIMR reference panels) before the licence issues. Cross-reactivity with other flaviviruses is a particular concern for dengue. Fix the analyte scope and build the designated-lab evaluation into the timeline, since it sits on the critical path.

Step-by-Step: CDSCO Registration Process

Confirm the classification. Fix the risk class against the CDSCO classification list and the First Schedule — Class C here — which decides the form, authority, fee and audit route.
Choose the route. Manufacture (Form MD-7 → MD-9) or import (Form MD-14 → MD-15). Importers appoint an Indian Authorised Agent holding a valid manufacturing or wholesale licence.
Build the Device Master File and Plant Master File. Assemble device description, materials, design and process data, the ISO 14971 risk file, sterilisation/stability data and the site file with the QMS.
Complete the Essential Principles checklist. Map the device against each applicable essential principle and cite the BIS/IS or ISO/IEC standard or test report relied on.
Draw the test and performance reports. Test to the applicable standards at an accredited laboratory; sterile and measuring devices carry additional validation.
Register and file on the CDSCO Medical Device Online portal. Create the account, pay the government fee online and upload the full dossier under the correct form.
Site audit / inspection. A CDSCO joint audit team inspects the manufacturing site before the licence is granted — site inspection is mandatory for Class C and D.
Respond to queries and receive the licence. Answer the deficiency letter within the stipulated period; on approval the licence issues in Form MD-9 (manufacture) or MD-15 (import).

Government Fees and Timeline

Fees are set in the Second Schedule of the Medical Devices Rules and paid online through the CDSCO portal. For manufacture of a Class C device the fee is Rs 50,000 per site plus Rs 1,000 for each distinct device, paid to the Central Licensing Authority (CDSCO headquarters). Import fees under Form MD-15 are charged per site and per device in USD — roughly USD 1,000 per site plus USD 50 per device for lower-risk devices, up to about USD 3,000 per site plus USD 1,500 per device for Class C and D. A test licence (Form MD-13) carries a modest fee. Always confirm the current figure on the CDSCO portal before filing.

A complete Class C manufacturing file is typically cleared in about six to nine months; an import (MD-15) file usually takes six to nine months. Every deficiency letter effectively restarts the clock. Unlike the old registration certificates, an MDR 2017 licence does not expire — it stays valid as long as the retention fee (equal to the licence fee) is paid every five years and the conditions of licence are met.

Common Mistakes That Trigger a CDSCO Query

Common query reasons for dengue/malaria IVD applications are:

Performance data not from a designated laboratory, or below required sensitivity/specificity.
An analyte claimed on the card without its own performance evidence.
Dengue kits without flavivirus cross-reactivity data.
Stability data not supporting the labelled shelf-life under Indian conditions.
Free Sale Certificate scope not covering the exact kit on import.

Related Approvals to Plan Alongside CDSCO

DGFT Importer-Exporter Code — mandatory for any importer of record before the first consignment.
Wholesale / sale licence (Form 20B/21B or Form MD-42) — for stocking and distributing the device; the Indian Authorised Agent for an import licence must already hold one.
Legal Metrology (LMPC) registration — importers of pre-packaged devices declare MRP, net quantity, importer details and country of origin on the pack.
BIS certification — where the device or its electrical components fall under a mandatory BIS/CRS scheme.

Post-Approval Obligations

Print the licence number on the label and keep the Essential Principles conformity current.
Operate a Post-Market Surveillance (PMS) system and file the Periodic Safety Update Report (PSUR) on the schedule for the device’s class.
Report adverse events and field safety corrective actions through the Materiovigilance Programme of India (MvPI) and to CDSCO within the prescribed timelines.
Report any change in device, materials, site, labelling or QMS, and any regulatory action or recall in another country.
Retain distribution records for traceability and allow CDSCO to draw samples and inspect the premises.
Pay the retention fee every five years to keep the licence in force, and track BIS/ISO standard revisions.

Frequently Asked Questions

What CDSCO class are dengue and malaria test kits?

They are Class C IVDs, so a domestic manufacturer files Form MD-7 for an MD-9 licence with the Central Licensing Authority, and an importer files Form MD-14 for an MD-15 licence.

Is designated-laboratory validation required?

Yes — dengue and malaria assay performance is validated at a designated evaluation laboratory (often ICMR/NIMR-linked) before the licence issues; confirm the current requirements.

Does each analyte need its own evidence?

Yes — every analyte claimed on the kit (dengue NS1/IgM/IgG; malaria Pf/Pv) must be supported by its own performance data.

Why does cross-reactivity matter for dengue?

Dengue shares antigens with other flaviviruses, so cross-reactivity data is expected to show the kit is specific.

How long does registration take?

Plan beyond the usual six to nine months where the designated-laboratory evaluation adds time to a complete Class C IVD file.

Does the licence expire?

No — the MDR 2017 licence is perpetual, subject to the five-yearly retention fee and continued compliance.

Why Choose PCN India Global

Classification triage — we confirm the correct risk class for your dengue & malaria test kits against the current CDSCO list before anything is drafted.
Route selection — manufacture (MD-5/MD-9) or import (MD-15), with the Indian Authorised Agent arrangement handled.
Dossier build — Device Master File, Plant Master File, Essential Principles checklist and ISO 13485/ISO 14971 readiness.
Standards and testing — the right BIS/IS or ISO/IEC standards mapped and accredited test reports coordinated.
End-to-end online filing — application, audit support, query response and the licence grant managed for you.
Adjacent approvals — DGFT/IEC, LMPC, wholesale/sale licence and BIS coordinated alongside your CDSCO licence.

PCN India Global manages the complete CDSCO process for dengue & malaria test kits — from classification and route selection to Device and Plant Master File preparation, online filing, audit support and the licence grant. WhatsApp or call +91 80109 05029, or email admin@pcnindiaglobal.com, to get your registration underway.

Related Compliance Guides

CDSCO Licence for Coronary Stents
CDSCO Registration for Syringes
CDSCO Licence for Surgical Gloves
CDSCO Licence for Ventilators